Similar articles

• Synthesis and antitumor activity of preactivated isophosphamide analogues bearing modified alkylating functionalities.

  Takamizawa A, Matsumoto S, Iwata T, Makino I, Yamaguchi K, Uchida N, Kasai H, Shiratori O, Takase S. Takamizawa A, et al. J Med Chem. 1978 Feb;21(2):208-14. doi: 10.1021/jm00200a013. J Med Chem. 1978. PMID: 621716
• Stereochemistry, metabolism, and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and its stereoisomer.

  Takamizawa A, Iwata T, Yamaguchi K, Shiratori O, Harada M. Takamizawa A, et al. Cancer Treat Rep. 1976 Apr;60(4):361-8. Cancer Treat Rep. 1976. PMID: 1277212
• Synthesis and antitumor activity of analogues of ifosfamide modified in the N-(2-chloroethyl) group.

  Misiura K, Kinas RW, Stec WJ, Kusnierczyk H, Radzikowski C, Sonoda A. Misiura K, et al. J Med Chem. 1988 Jan;31(1):226-30. doi: 10.1021/jm00396a036. J Med Chem. 1988. PMID: 3336021
• Ifosfamide in experimental tumor systems.

  Goldin A. Goldin A. Semin Oncol. 1982 Dec;9(4 Suppl 1):14-23. Semin Oncol. 1982. PMID: 6761864 Review. No abstract available.
• Cyclophosphamide versus ifosfamide: to use ifosfamide or not to use, that is the three-dimensional question.

  Williams ML, Wainer IW. Williams ML, et al. Curr Pharm Des. 1999 Aug;5(8):665-72. Curr Pharm Des. 1999. PMID: 10469897 Review.